TickerFactsScreenerDevelopers

Evofem Biosciences, Inc. (EVFM) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $21.2K2014: $18.1K2015: $226.1K2017: $6.0K2018: $7.0K2019: $164.0K2020: $2.25M2021: $2.94M2022: $341.0K2023: $4.0K2024: $14.0K2025: $5.0K$5.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$5.0K-64.3%
2024$14.0K+250.0%
2023$4.0K-98.8%
2022$341.0K-88.4%
2021$2.94M+30.4%
2020$2.25M+1274.4%
2019$164.0K+2242.9%
2018$7.0K+16.7%
2017$6.0K—
2015$226.1K+1150.8%
2014$18.1K-14.6%
2013$21.2K—